Health care failure mode and effect analysis: A useful proactive risk analysis in a pediatric oncology ward

Quality and Safety in Health Care

Volumn 15, Issue 1, 2006, Pages 58-64

  Van Tilburg, C M ^a   Leistikow, I P ^a   Rademaker, C M A ^a   Bierings, M B ^a   Van Dijk, A T H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HOSPITAL MANAGEMENT; HUMAN; ONCOLOGY WARD; PHARMACY; PRESCRIPTION; RISK ASSESSMENT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; CHILD, PRESCHOOL; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MEDICAL ERRORS; MEDICAL ONCOLOGY; NETHERLANDS; PATIENT CARE TEAM; PRESCRIPTIONS, DRUG; QUALITY ASSURANCE, HEALTH CARE; RISK ASSESSMENT; SAFETY MANAGEMENT; VINCRISTINE;

EID: 33244459378     PISSN: 14753898     EISSN: None     Source Type: Journal    
DOI: 10.1136/qshc.2005.014902     Document Type: Article

References (21)

1. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991;324:370-6.
2. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC National Academy Press, 1999.
3. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991;324:377-84.
4. Flekher CE. Failure mode and effects analysis. An interdisciplinary way to analyze and reduce medication errors. J Nurs Admin 1997;27:19-26.
5. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-20.
6. Wilson DG, McArtney RG, Newcombe RG, et al. Medication errors in paediatric practice: insights from a continuous quality improvement approach. Eur J Pediatr 1998;157:769-74.
7. Slats AM, Egeler RM, van der Does-van den Berg, et al. Causes of death-other than progressive leukemia-in childhood acute lymphoblastic (ALL) and myeioid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia 2005;19:537-44.
8. Fernandez CV, Esau R, Hamilton D, et al. Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention. J Pediatr Hematol Oncol 1998;20:587-90.
9. Dyer C. Doctors suspended after injecting wrong drug into spine. BMJ 2001;322:257.
10. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995;274:35-43.
11. Apkon M, Leonard J, Probst L, et al. Design of a safer approach to intravenous drug infusions: failure mode effects analysis. Qual Saf Health Care 2004;13:265-71.
12. Womer RB, Tracy E, Soo-Hoo W, et al. Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains. J Clin Oncol 2002;20:4705-12.
13. DeRosier J, Stalhandske E, Bagian JP, et al. Using health care failure mode and effect analysis: the VA National Center for Patient Safety's prospective risk analysis system. Jt Comm J Qual Improv 2002;28:248-67, 209.
14. Stalhandske E, DeRosier J, Patail B, et al. How to make the most of failure mode and effect analysis. Biomed Instrum Technol 2003;37:96-102.
15. Landrigan CP, Rothschild JM, Cronin JW, et al. Effect of reducing interns' work hours on serious medical errors in intensive care units. N Engl J Med 2004;351:1838-48.
16. Volpp KG, Grande D. Residents' suggestions for reducing errors in teaching hospitals. N Engl J Med 2003;348:851-5.
17. Revesz T, Bierings M, Rademaker C. New technique for the intrathecal administration of chemotherapeutic agents. Med Pediatr Oncol 2000;34:72-3.
18. Adachi W, Lodolce AE. Use of failure mode and effects analysis in improving the safety of iv drug administration. Am J Health Syst Pharm 2005;62:917-20.
19. Duwe B, Fuchs BD, Hansen-Flaschen J. Failure mode and effects analysis application to critical care medicine. Crit Care Clin 2005;21:21-30, vii.
20. Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal intensive care. Drug Saf 2005;28:251-61.
21. Linkin DR, Sausman C, Santos L, et al. Applicability of healthcare failure mode and effects analysis to healthcare epidemiology: evaluation of the sterilization and use of surgical instruments. Clin Infect Dis 2005;41:1014-9.